Bulletin from annual general meeting in Senzime AB (publ)
2023-05-16 17:45
New CEO of Senzime
2023-05-03 17:45
Neuromuscular blockade management guidelines
New guidelines recommend Senzime's type of technology
Latest guidelines from both European Society of Anaesthesiology and Intensive Care (ESAIC) and American Society of Anesthesiologists (ASA) strongly recommend the use of quantitative neuromuscular monitoring to prevent complications.
TetraGraph is a quantitative neuromuscular monitor, based on state-of-the-art EMG technology, enabling you as a clinican to make confident decisions from start to finish of a procedure.
A Swedish medical device company
Senzime develops, manufactures and markets CE- and FDA-cleared patient monitoring systems.
Our vision is a world without anesthesia and respiratory-related complications.
